Joyance 2

Joyance Partners, established in 2012 and headquartered in San Francisco, is a venture capital firm focusing on early-stage investments. It specializes in startups and emerging technologies that empower individuals to improve their health and well-being, with a particular interest in health tech and consumer sectors. The firm invests in companies that leverage science and technology to cultivate joy and enhance lives, targeting pre-seed to Series A rounds in the United States, Canada, and Europe.

Omar Al-Busaidi

Investment Partner and Venture Partner

Yang Chen

Investor

Jun Deng Ph.D

Investment Partner

Sonia Dewar

Investment Partner

Mike Edelhart

Managing Partner

Toshi Eguchi

Managing Director, Joyance Asia

Jim Louderback

Venture Partner

Hidenari Nakayama Ph.D

Venture Partner, Joyance Partners

Neal O'Hara

Venture Partner

Seth Rosenblatt

Venture Partner

Charles Smith

Venture Partner

Nobuhiro Takanuma

Partner, Joyance Partners

Neha Tanna

Venture Partner

Bradley Welch

Venture Partner

Past deals in Dietary Supplements

Spicewell

Seed Round in 2024
Spicewell is a California-based company that specializes in developing and manufacturing innovative food seasoning products infused with micronutrients. By leveraging modern scientific advancements, Spicewell creates plant-based seasonings that incorporate healthy and organic ingredients, enhancing the nutritional value of meals. The product range includes various seasonings, such as salt and pepper, which are designed to provide essential vitamins and minerals. Ultimately, Spicewell aims to promote better health through its science-backed formulations, offering customers a unique approach to seasoning that combines culinary enjoyment with health benefits.

mybacs

Series A in 2023
mybacs GmbH is a Swiss company founded in 2018, specializing in microbiome health through the development of synbiotic dietary supplements. Based in Baar, the company focuses on enhancing intestinal healthcare and overall well-being for its customers. mybacs offers a range of travel health supplements tailored for various regions, including Asia, Africa, the Middle East, Europe, North America, and Latin America. The products are formulated by a team of pharmaceutical scientists and physicians, using carefully selected probiotic cultures, prebiotics, vitamins, and minerals to meet individual customer needs. All supplements are designed to be gluten-free and lactose-free, ensuring they are accessible to a broad audience while promoting improved digestion and preventing gastrointestinal issues.

Mosh

Series A in 2023
Mosh is a brain wellness brand offering protein bars for improving brain health. The company's mission is to change the conversation about brain health through food, education, research, and providing the tools for a mind-style lifestyle.

Sigrid Therapeutics

Venture Round in 2021
Sigrid Therapeutics AB is a clinical-stage biotechnology company based in Stockholm, Sweden, focused on developing innovative therapeutic products aimed at preventing and treating lifestyle diseases. The company has created a novel materials platform designed to alter food digestion in the body. Its lead product is an ingested medical device intended to lower blood sugar levels in prediabetics, representing a new approach to managing chronic conditions related to modern lifestyles. By targeting the gut, Sigrid Therapeutics seeks to help individuals achieve weight loss and overall better health outcomes.

Infinite Roots

Series A in 2020
Infinite Roots is a technology-driven company focused on creating sustainable health and wellness products using natural ingredients. The company specializes in fermentation technology, particularly the cultivation of mushroom mycelium, to produce healthy and eco-friendly foods. Their product range includes herbal supplements, skincare solutions, and meat alternatives, all designed to support holistic well-being and environmental sustainability. Infinite Roots is committed to using organic and ethically sourced materials, blending traditional remedies with modern science to promote natural healing and balance.

mybacs

Seed Round in 2020
mybacs GmbH is a Swiss company founded in 2018, specializing in microbiome health through the development of synbiotic dietary supplements. Based in Baar, the company focuses on enhancing intestinal healthcare and overall well-being for its customers. mybacs offers a range of travel health supplements tailored for various regions, including Asia, Africa, the Middle East, Europe, North America, and Latin America. The products are formulated by a team of pharmaceutical scientists and physicians, using carefully selected probiotic cultures, prebiotics, vitamins, and minerals to meet individual customer needs. All supplements are designed to be gluten-free and lactose-free, ensuring they are accessible to a broad audience while promoting improved digestion and preventing gastrointestinal issues.

WholyMe

Seed Round in 2020
WholyMe Ltd, founded in 2018 and based in London, United Kingdom, specializes in producing natural relief products aimed at alleviating chronic pain and everyday stress. The company offers a range of all-natural and organic-certified wellness remedies, which include effective supplements and topical applications. WholyMe's products are free from preservatives, parabens, chemicals, and synthetics, providing customers with alternative solutions to conventional painkillers known for their adverse side effects. The focus on healthy, effective relief options reflects the company's commitment to delivering natural alternatives for pain management.

Infinite Roots

Venture Round in 2019
Infinite Roots is a technology-driven company focused on creating sustainable health and wellness products using natural ingredients. The company specializes in fermentation technology, particularly the cultivation of mushroom mycelium, to produce healthy and eco-friendly foods. Their product range includes herbal supplements, skincare solutions, and meat alternatives, all designed to support holistic well-being and environmental sustainability. Infinite Roots is committed to using organic and ethically sourced materials, blending traditional remedies with modern science to promote natural healing and balance.

Sigrid Therapeutics

Venture Round in 2019
Sigrid Therapeutics AB is a clinical-stage biotechnology company based in Stockholm, Sweden, focused on developing innovative therapeutic products aimed at preventing and treating lifestyle diseases. The company has created a novel materials platform designed to alter food digestion in the body. Its lead product is an ingested medical device intended to lower blood sugar levels in prediabetics, representing a new approach to managing chronic conditions related to modern lifestyles. By targeting the gut, Sigrid Therapeutics seeks to help individuals achieve weight loss and overall better health outcomes.

Infinite Roots

Convertible Note in 2019
Infinite Roots is a technology-driven company focused on creating sustainable health and wellness products using natural ingredients. The company specializes in fermentation technology, particularly the cultivation of mushroom mycelium, to produce healthy and eco-friendly foods. Their product range includes herbal supplements, skincare solutions, and meat alternatives, all designed to support holistic well-being and environmental sustainability. Infinite Roots is committed to using organic and ethically sourced materials, blending traditional remedies with modern science to promote natural healing and balance.

Solarea Bio

Seed Round in 2018
Solarea Bio, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing microbial therapeutics to address health disorders linked to chronic inflammation. Founded in 2017, the company utilizes a platform that combines microbial discovery and genomics to create synergistic microbial assemblages using bacteria and fungi derived from healthy foods. Solarea Bio generates an extensive database of complete genomic sequences of these microbes and employs computational approaches to formulate combinations that exhibit strong anti-inflammatory properties. The company's therapeutics aim to prevent or mitigate health issues associated with chronic inflammation, with initial applications targeting dietary management of metabolic conditions like osteopenia and osteoporosis in postmenopausal women. Through its innovative approach, Solarea Bio seeks to enhance the quality of life by providing nature-based solutions for various health challenges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.